直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Updated PTAB Guidance on Use of Applicant Admitted Prior Art in IPRs

November 4, 2022

Authored and Edited by Yinan Liu, Ph.D.; Shannon M. Patrick; Amanda K. Murphy, Ph.D.

Following the Federal Circuit’s decision in Qualcomm Inc. v. Apple Inc., 24 F.4th 1367 (Fed. Cir. 2022), on June 9, 2022, the USPTO Director Katherine K. Vidal issued an updated guidance memorandum to supersede the prior August 18, 2020 guidance on the treatment of applicant statements during an IPR .

Section 311(b) limits the prior art that may be used as “the basis” of an IPR proceeding to “patent[s] or printed publications.” However, IPR petitions sometimes rely on statements in the specification of the challenged patent, which are generally referred to as “admissions,” “applicant-admitted-prior-art,” or “AAPA.” The updated memorandum sets forth the extent to which admissions or AAPA may be used in IPR proceedings.

In Qualcomm, the court clarified that it is “impermissible for a petition to challenge a patent relying on solely AAPA without also relying on a prior art patent or printed publication.” On the other hand, if an IPR petition relies on admissions in combination with reliance on one or more prior art patents or printed publications, those admissions do not form “the basis” of the ground and must be considered by the Board in its patentability analysis.

The updated memorandum provides guidance to litigants that admissions are “permissible evidence in an inter partes review for establishing the background knowledge possessed by a person of ordinary skill in the art” and “provide a factual foundation as to what a skilled artisan would have known at the time of invention.” For example, a patentee’s admissions can be used to: “(1) supply missing claim limitations that were generally known in the art prior to the invention (for pre-America Invents Act (AIA) patents) or the effective filing date of the claimed invention (for post-AIA patents); (2) support a motivation to combine particular disclosures; or (3) demonstrate the knowledge of the ordinarily-skilled artisan at the time of the invention (for pre-AIA patents) or the effective filing date of the claimed invention (for post-AIA patents) for any other purpose related to patentability.”

In addition to assisting parties in crafting their IPR arguments, the updated guidance on AAPA also serves as a warning to patent applicants that admissions made in the specification could ultimately be used in future invalidity arguments.

Tags

Patent Trial and Appeal Board (PTAB), United States Patent and Trademark Office (USPTO)

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Atlanta, GA

Boston, MA

London

Contacts

Yinan Liu, Ph.D.
Associate
Boston, MA
+1 617 646 1652
Email
Shannon M. Patrick
Associate
Atlanta, GA
+1 404 653 6558
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email

Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP